Thyroid Eye Disease (TED) Clinical Trials
2 recruiting trials for Thyroid Eye Disease (TED). Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
1
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGPhase 3NCT07262476
Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease
This is a multicenter, open-label extension (OLE) study of MHB018A in subjects with moderate-to-severe TED.
Sponsor: Minghui Pharmaceutical (Hangzhou) LtdEnrolling: 2581 location
RECRUITINGPhase 1NCT06569758
A Study of GenSci098 in Subjects With Active Thyroid Eye Disease
To evaluate the safety and tolerability of single and multiple ascending subcutaneous doses of GenSci098 in patients with thyroid eye disease (TED)
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.Enrolling: 761 location